Determination of nitric oxide (NO) synthesis in vivo is essential to understand the pathophysiologic role and therapeutic implications of the L-arginine/NO pathway in pediatric diseases. The aim of this study was to establish a noninvasive, sensitive, specific, and reliable approach to determine whole-body NO synthesis in healthy children. Seventeen healthy children (eight boys/nine girls, 4 -16 y) were studied twice, and six of them on three occasions. Fasting children received a single oral dose of nonradioactive T he L-arginine/NO pathway has been an exciting research area for the past two decades. NO is endogenously synthesized from the amino acid L-arginine by NO synthase (NOS) in numerous cells, including platelets, neurons, macrophages, and endothelial cells (1). Three isoforms of human NOS have been cloned: neuronal, endothelial, and inducible (2). Both the neuronal NOS and endothelial NOS are constitutively expressed in cells and produce picomolar amounts of NO. By contrast, the inducible isoform produces high and sustained levels of NO and is usually expressed in macrophages and vascular smooth muscle cells following the exposure to cytokines and lipopolysaccharide (3). The physiologic importance of the L-arginine/NO pathway has been extensively studied in humans. It is known to play a major role in controlling vascular tone, platelet function, neurotransmission, and bronchial airway reactivity (1,4).Basic research on NO derived from in vitro and in vivo experimental models has started to have an impact on pediatrics. Accumulating evidence suggest that the NO signaling pathway is abnormal in a number of pediatric conditions including primary pulmonary hypertension (5), childhood essential hypertension (6), and cerebral malaria (7) and markedly increased in others such as septic shock (8), gastroenteritis (9,10), bronchial asthma (11), type 1 diabetes mellitus (12), and autoimmune and inflammatory diseases (13). Accurate and reliable determination of NO synthesis in vivo is essential to understand the pathophysiologic and therapeutic roles of this biologic pathway. Direct measurement of exhaled NO is a noninvasive and practical approach for assessing airway inflammation in children (14). Indeed, exhaled NO has been proposed as a tool for screening and monitoring airway inflammation and titration of anti-inflammatory therapy in asthmatic children (15). On the other hand, determination of systemic NO synthesis has been proved difficult because of NO's short plasma half-life (3-5 s) (16). This limitation has led to the development of functional and chemical markers to determine NO bioactivity. Biomarkers such as cyclic guanosine monophosphate, L-citrulline, and nitrate concentrations in plasma and urine have been used in clinical studies to assess systemic NO synthesis. However, these metabolites are not specific for the L-arginine/NO pathway (17). An approach to assess whole-body NO synthesis in critically ill children (i.e. septic shock) consists of a primed, 5-8-h constant i.